Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Regeneron Pharmaceuticals, Inc. (REGN)
Portfolio Pulse from
A class action lawsuit has been filed against Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) by Gainey McKenna & Egleston. The lawsuit is on behalf of investors who acquired Regeneron securities between November 2, 2023, and October 30, 2024, seeking damages under federal securities laws.
January 08, 2025 | 11:30 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Regeneron Pharmaceuticals is facing a class action lawsuit filed by Gainey McKenna & Egleston, which could impact its stock price negatively in the short term.
The announcement of a class action lawsuit typically leads to negative sentiment among investors, potentially causing a short-term decline in stock price. The lawsuit seeks damages for investors, which could imply financial and reputational risks for Regeneron.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100